Global incidence of malaria has risen 8.5 percent over the past decade while dengue infections approach 400 million annually. Researchers emphasize that preventing these vector-borne and zoonotic disease outbreaks requires coordinated One Health approaches rather than any single intervention strategy.
Climate change is actively reshaping the geographic reach of disease vectors, expanding the territories where Anopheles and Aedes mosquitoes can survive and thrive. As rising temperatures and altered rainfall patterns alter environmental conditions, public health researchers are confronting a complex web of ecological, epidemiological, and socioeconomic factors that influence how malaria and dengue spread across populations, according to a Monash University review published in Science Advances.
Divergent Trajectories of Malaria and Dengue Under Global Warming
Malaria is a serious, life-threatening parasitic infection transmitted through the bites of infected female Anopheles mosquitoes, whereas dengue is caused by a virus spread by infected female Aedes mosquitoes. Worldwide, communities record close to 300 million cases of malaria and almost 400 million dengue infections every year. Yet these two major vector-borne diseases have followed distinctly different paths over the last century.
Lead researcher Dr Toby Cumming, a research fellow in the Health and Climate Initiative at the Monash School of Public Health and Preventive Medicine, noted that while climate factors exert broadly similar pressures on both mosquito populations, their real-world outcomes diverge sharply. Yet over the last century, during a time of unambiguous warming, rates of malaria have declined while rates of dengue have risen,
Dr Cumming said.
Non-climate drivers help explain this split. Major gains in reducing malaria came from targeted drug therapies and mosquito control interventions. Meanwhile, increasing urbanization has favored Aedes mosquitoes, fueling the spread of dengue—a virus that currently lacks therapeutics. Even with malaria in long-term decline, global incidence increased 8.5 percent over the past decade, prompting warnings from researchers that there is no room for complacency.
University College London Findings on Zoonotic Spillover Risks
Beyond mosquito-borne infections, broader research into emerging infectious diseases and zoonotic pathogens reveals that environmental disruptions do not follow a simple predictive formula. A study by scientists at University College London (UCL) and other institutions demonstrates that deforestation, agricultural intensification, and climate warming affect disease outbreaks differently depending on the specific pathogen involved.
The UCL team discovered that apparent disease hot spots often reflect the strength of local health infrastructure rather than true biological distribution. The probability of reporting an emerging disease outbreak dropped by an average of 32 percent for every additional hour of travel required to reach the nearest healthcare facility. According to the authors, areas with comprehensive disease surveillance detect and report events more effectively than isolated regions.
One Health Approaches Help Prevent Disease Outbreaks
Addressing both zoonotic spillover and mosquito-borne threats requires moving beyond isolated fixes. Investigators emphasize that surveillance systems must expand hand-in-hand with grassroots healthcare access so authorities can catch outbreaks before they escalate into epidemics or pandemics.
Spillover disease outbreaks are multi-causal, shaped by the socioecological system; this really highlights the need for One Health integrated approaches to surveillance and intervention—there is no single intervention strategy.
To combat dengue specifically, novel preventive interventions are entering the public health toolkit. These include vaccines and innovative vector control methods, such as introducing the bacterium Wolbachia into Aedes mosquito populations to suppress their capacity to transmit the virus. Developed by the World Mosquito Program—a not-for-profit group of companies owned by Monash University—these strategies form part of the broader, multi-pronged framework that researchers say is essential for addressing the many climate and non-climate factors driving global disease spread.